Holen Sie sich die Stockscreener-App
32.26
0.67%
0.2149
Handel nachbörslich:
32.26
0.0014
+0.00%
Schlusskurs vom Vortag:
$32.04
Offen:
$32
24-Stunden-Volumen:
21,211
Relative Volume:
1.42
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.53%
1M Leistung:
+18.19%
6M Leistung:
+68.98%
1J Leistung:
+13.47%
1-Tages-Spanne:
$31.95
$32.35
1-Wochen-Bereich:
$30.93
$32.50
52-Wochen-Spanne:
$13.42
$32.50
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
Virtus Lifesci Biotech Clinical Trials Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
32.26 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.42 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.06 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.99 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
629.07 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
Biotech ETF (BBC) Hits New 52-Week High - MSN
Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price, news, quote and history - Yahoo! Finance UK
Biotech ETFs Hovering Around a 52-Week: Here's Why - Nasdaq
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Can Virtus LifeSci Biotech Clinical Trials stock deliver strong annual returns2025 Pullback Review & Fast Entry Momentum Alerts - nchmf.gov.vn
Discipline and Rules-Based Execution in BBC Response - news.stocktradersdaily.com
Trade War or Not, Specific Industry ETFs Are in Sweet Spots - TradingView
What MACD trends signal for Virtus LifeSci Biotech Clinical Trials stockWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Best-Performing ETFs of Last Week - sharewise.com
Canadian Equities Shine: ETFs to Capture the Momentum - The Globe and Mail
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
Wall Street Week Ahead - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Stock Trends and Sentiment 2025 - MarketBeat
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal - ETF Trends
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
How to Pick a Biotech ETF - Investment U
Positioning for Biotech Bounceback - ETF Trends
Make Biotech Cash Considerations With SBIO - ETF Trends
Some Biotech Stocks Are Now Cheap - ETF Trends
Biotech M&A Could Finally Perk Up in 2022 - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Biotech Stocks Have Colds, but They Can Heal - ETF Trends
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - ETF.com
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Nasdaq
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):